MINNEAPOLIS--(BUSINESS WIRE)--The National Institute for Pharmaceutical Technology and Education (NIPTE) and U.S. Pharmacopeia (USP) today announced the initiation of a joint effort to create the ...

CAMBRIDGE, MA -- A three-year research program led by faculty at MIT aims to design the world’s first fully integrated, continuous mRNA manufacturing platform, in an $82 million effort funded by the U ...

Eli Lilly’s breast cancer med Verzenio may look like your standard drug tablet—ovular, off-white, emblazoned with the dosage on the front and Lilly’s logo on the reverse—but behind that modest façade ...

Continued process verification (CPV) is the third stage of the product lifecycle of any medicine either within the small or large molecule arena. The CPV is the subsequent step to process design ...

Basel-based Lonza joined CMAC, a center for medicines manufacturing research, to enhance its service offering for particle technologies and drug product development and manufacture. Based at the ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

Historically, pharmaceutical products have been produced in a traditional ‘batch’ system, in which every operation is executed separately using a defined quantity of materials. In batch manufacturing ...